Celldex Therapeutics (CLDX) Posts Mixed Q4 Results

March 7, 2013 8:06 AM

Celldex Therapeutics (NASDAQ: CLDX) reported Q4 EPS of ($0.27), $0.02 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found